Patent foramen ovale
- 16 April 2020
- journal article
- research article
- Published by BMJ in Practical Neurology
- Vol. 20 (3) , 225-233
Abstract
Patent foramen ovale (PFO) is the most common anatomical cause of an interatrial shunt. It is usually asymptomatic but may cause paradoxical embolism, manifesting as stroke, myocardial infarction or visceral/peripheral ischaemia. PFO is a risk factor for stroke and may be associated with migraine with aura. New evidence suggests PFO closure reduces the risk of recurrent ischaemic stroke in a highly selected population of stroke survivors: those aged 60 years or younger with a cryptogenic stroke syndrome, a large right-to-left shunt, an atrial septal aneurysm and no evidence of atrial fibrillation. They benefit from percutaneous PFO closure in addition to antiplatelet therapy, rather than antiplatelet therapy alone. Current evidence does not support PFO closure in the treatment of migraine.Keywords
This publication has 71 references indexed in Scilit:
- Prevalence of cardiac right left shunts in migraine: a population-based case–control studyNeurological Sciences, 2012
- Role of Patent Foramen Ovale in Migraine Etiology and Treatment: A ReviewEchocardiography, 2011
- Patent Foramen Ovale in Cryptogenic StrokeStroke, 2009
- Patent Foramen Ovale and MigraineCirculation, 2008
- Right-to-Left Shunt in CADASIL PatientsStroke, 2008
- Prevalence of Patent Foramen Ovale and Usefulness of Percutaneous Closure Device in Carcinoid Heart DiseaseThe American Journal of Cardiology, 2008
- Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical StatusJACC, 2005
- Is Patent Foramen Ovale a Family Trait?Stroke, 2001
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996
- Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients.Stroke, 1993